Skrekas et al. omitted the gastrografin study. Patients were discharged as soon as they were able to tolerate a liquid diet and were advised to progress to a once soft diet after 15 days and to solid food after 30 days. Proton pump inhibitors and anticoagulation with low-molecular weight-heparin were prescribed regularly for 2 months and 14 days, respectively. During the first six postoperative months, all patients were treated with multivitamins and iron supplements. Follow-up visits were scheduled. 7. Results Laparoscopic Sleeve Gastrectomy (LSG) has been in many ways the Holy Grail of Bariatric Surgery. A relatively simple technique, with short operating time, few complications, and very good results in Excess Weight Loss. LGCP is being proposed as a different way to reproduce the same results with even fewer complications.

According to the Third International Summit on the status of LSG [16], these results are a reported mean percentage of excess weight loss at 1, 2, 3, 4, and 5 years of 62.7%, 64.7%, 64.0%, 57.3%, and 60.0%, respectively. The issue of coexistence of GERD or a hiatal hernia is a particular problem, as LSG has been recognized as a factor which worsens or even produces new onset of GERD symptoms (probably through a stasis mechanism). Based on a survey involving 88 surgeons who had performed 19605 LSG’s, complications include staple-line leak, which is the most feared complication, at a rate from 0 to 10% (mean 1.3 �� 2.0) for high leaks at the level of the gastroesophageal junction, 0 to 10% (mean 0.5 �� 1.8) for lower leaks, 0 to 40% (mean 2.0 �� 5.

0) for hemorrhage, splenic injury in 0 to 10% (mean 0.3, sd 1.3), liver injury in 0 to 7% (mean 0.2 �� 0.9), stricture in 0�C5% (mean 0.6 �� 1.1), and other complications in 0 to 38% (mean 2.4 �� 8.4). Mortality rate was assessed at 0.1% with a standard deviation of 0.3. In the 2011 Skrekas et al. Publication [9], 135 patients were studied (evidence Level III). Mean operative time was 58min (45�C80min), mean hospital stay was 1.9 days (1�C6 days), and mean followup was 22.59 months (8�C31 months). Preoperatively, the group of patients had a mean Total Body Weight (TBW) of 113.3 �� 22.5 and a mean BMI of 39.5 �� 17.3. On followup, the percentage of excess weight loss (%EWL) was 51.7% at 6 months, 67.1% at 12 months, and 65.2% at 24 months. Postoperative mean TBW was 83.5 �� 17.

3 and mean BMI was 29.6 �� 4.9. Inadequate weight loss (defined as less than 50% of the %EWL) was observed in 21.48%, with failure (%EWL of less than 30%) in 5.9% of the cases of inadequate weight loss. After subgroup analysis, the authors found that the results in weight loss were better in the group with a BMI of less than 45. Modification of their technique with formation of a double plication had no effect on weight loss. Total complication rate was 8.8% (12/135). Four patients presented nausea and vomiting which persisted Carfilzomib for a few days.